Research assistant professor, at Peking University Third Hospital, China.
Dr. Fu Weiwei is an accomplished medical scientist specializing in gastroenterology and immunology. She currently serves as an Assistant Research Professor and Laboratory Director at the Gastroenterology Department, Peking University Third Hospital, where she leads research at the Beijing Key Laboratory. Dr. Fu earned her Ph.D. in Immunology from Peking University Health Science Center and has a strong foundation in traditional medicine, holding a Bachelor of Medicine from Shandong University. With more than a decade of experience in translational medical research, her work bridges cutting-edge immunological discoveries and practical clinical applications. Her focus lies in immune microenvironment dynamics, gastrointestinal tumor evolution, and the integration of traditional Chinese medicine for digestive disease therapies. She has delivered several high-profile international presentations and has published widely in leading scientific journals. Her contributions have significantly advanced the field of digestive immunology.
Professional Profile
Scopus
ORCID
🎓 Education
Dr. Fu’s academic journey began with a 5-year Bachelor of Medicine program at Shandong University of Traditional Chinese Medicine (2002–2007), where she laid a solid foundation in both conventional and traditional healthcare practices. Her early exposure to integrative medicine inspired a unique perspective on digestive health and immune response. Motivated by scientific rigor, she enrolled in the Combined Master’s and Ph.D. Program in Immunology (2008–2013) at Peking University Health Science Center, mentored by Prof. Wenling Han. This elite program sharpened her skills in molecular biology, immunopathology, and clinical translational research. Throughout her doctoral years, she focused on the host immune responses in cancer, particularly those related to gastric inflammation and tumorigenesis. This diverse academic training enables her to merge modern biomedical technologies with traditional insights, giving her an edge in the multidisciplinary field of digestive immunology.
🧪 Experience
Dr. Fu brings a wealth of research and clinical experience to her current position at the Gastroenterology Department, Peking University Third Hospital (2019–present), where she directs the Beijing Key Laboratory. As an Assistant Research Professor, she leads a team focusing on translational immunology in gastrointestinal diseases. Before this, she completed a prestigious postdoctoral fellowship (2013–2019) at the Tsinghua University Institute of Immunology under Prof. Chen Dong, an Academician of the Chinese Academy of Sciences. During this time, she worked on T-cell signaling, immune checkpoints, and the role of lymphoid cells in cancer. Her lab currently integrates clinical cohort data with multi-omics techniques to explore disease mechanisms. She is also instrumental in mentoring junior researchers and clinicians. Her work bridges laboratory immunology with bedside applications, ensuring scientific advancements are translated into improved diagnosis and therapy for patients.
🔬 Research Interests
Dr. Fu’s research centers on the immune microenvironment in gastrointestinal tumors and digestive tract diseases, such as gastric cancer and inflammatory bowel disease. She applies multi-omics technologies—including single-cell RNA sequencing, proteomics, and microbiome analysis—to decipher host-pathogen interactions and immune cell dynamics during disease evolution. A key aspect of her research is understanding how Helicobacter pylori infection initiates gastric lesions, tumor progression, and immune escape. She also investigates traditional Chinese medicine-based therapies, exploring their role in cancer prevention and immune modulation. Another focal point is early screening and biomarker discovery for precancerous lesions through clinical cohort studies. By integrating high-throughput data with clinical insights, her work aims to improve patient stratification and individualized treatments. Her interdisciplinary approach bridges immunology, oncology, and traditional medicine, placing her at the forefront of gastrointestinal research in China and beyond.
🏆 Awards
Dr. Fu’s scientific excellence has been consistently recognized. She won the Outstanding Paper Award at the 2023 Chinese Medical Association’s National Conference on Digestive Diseases (CGC 2023) for her oral presentation on immune profiling during colorectal cancer progression. Her continuous contributions to clinical immunology, translational oncology, and molecular diagnostics have earned her accolades from both national and international platforms. Her selection as an oral presenter at leading conferences—such as DDW 2024 in Washington, D.C., and UEGW 2023 in Copenhagen—speaks to her international recognition. She has also received patent grants for innovations in inflammation and cancer therapy, reflecting her drive for practical applications. As a dedicated researcher, educator, and innovator, Dr. Fu stands out as a top candidate for award nominations in the fields of biomedical research and clinical translational science.
📚 Top Noted Publications
Dr. Fu has authored and co-authored numerous impactful papers in top-tier journals (JCR Q1–Q3), often as first or corresponding author. Below are select publications with hyperlink.
2025
-
Luteolin Improves Precancerous Gastric Mucosa by Binding STAT3
International Journal of Biological Sciences (Q1, IF 8.1)
📌 Co-Corresponding Author
🧪 Original Research
-
CMTM3 Regulates Colitis-Associated Cancer Progression
Cellular and Molecular Gastroenterology and Hepatology (CMGH) (Q1, IF 7.1)
📌 Co-Corresponding Author
🧬 Original Research
-
Cmtm4 Deficiency Exacerbates H. pylori-Induced Gastric Carcinogenesis
Pathology International (Q2, IF 2.5)
📌 Co-Corresponding Author
🦠 Original Research
-
The Host Immune Response Landscape in Gastric Cancer Development
Clinical and Experimental Immunology (Q2, IF 3.4)
📌 First Author
🧫 Original Research
2024
-
Neutrophil Heterogeneity in Hepatocellular Carcinoma and Tumor Immunity
Cancer Medicine (Q2, IF 2.9)
📌 Co-First Author
🔬 Original Research
-
Oxidative Balance in Diet and Sleep Patterns: A Metabolic Interaction
Frontiers in Nutrition (Q2, IF 4.0)
📌 Co-First Author
🍽 Original Research
-
CMTM4 Facilitates Gastric Cancer Metastasis via EMT Modulation
Journal of Gastrointestinal Oncology (Q3, IF 2.0)
📌 Co-First Author
🧠 Original Research
-
Cmtm4 Shapes Colitis Outcomes via Microbial Dysbiosis and Mucosal Immunity
Journal of Genetics and Genomics (Q1, IF 6.6)
📌 Co-Corresponding Author
🧪 Original Research
-
Serum Proteomics-Based Biomarkers of Precancerous Gastric Lesions
Frontiers in Molecular Biosciences (Q2, IF 3.9)
📌 Co-Corresponding Author
🔍 Original Research
-
Treg Subsets Orchestrate Tumor Microenvironment in Colorectal Cancer
Frontiers in Immunology (Q1, IF 5.7)
📌 Co-First & Corresponding Author
🧫 Original Research
2023
-
Helicobacter pylori and Inflammasome Activation in Gastric Pathogenesis (Review)
Helicobacter (Q2, IF 4.3)
📌 Co-Corresponding Author
🧯 Review Article
2022
-
Lymphocyte Profile Alterations in Precancerous Gastric Lesions
Journal of Leukocyte Biology (Q2, IF 5.5)
📌 First Author
🧬 Original Research
-
B7 Family Molecules and Immune Evasion in H. pylori Infection (Review)
Helicobacter (Q2, IF 4.4)
📌 Co-Corresponding Author
🧫 Review Article
Conclusion
Dr. FU Weiwei demonstrates an exceptional and well-rounded profile as a medical researcher with significant contributions to immunology and gastroenterology, supported by prestigious academic training, a robust scientific publication record, impactful patents, and strong conference presence. These achievements, particularly in translational cancer immunology, make Dr. Fu highly suitable for the Best Researcher Award.